AK Medical Holdings Limited (incorporated in the Cayman Islands with limited liability, stock code 01789) released a Next Day Disclosure Return confirming share repurchases on 6 February 2026 and 13 February 2026. On 6 February 2026, 0.64 million shares were repurchased at HKD 5.92 per share. On 13 February 2026, 1.09 million shares were repurchased at prices ranging from HKD 6.15 to HKD 6.24, with the aggregate price paid at HKD 6.76 million.

The total issued shares remain at 1.12 billion as of 13 February 2026. Under a repurchase mandate dated 18 June 2025, the company is authorized to repurchase up to 0.11 billion shares. As of 13 February 2026, 1.73 million shares in total have been repurchased under this mandate, representing approximately 1.54% of the total issued shares as of the date of that resolution. A moratorium preventing any new share issuance or the sale of treasury shares remains in effect until 15 March 2026.